A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma
2017 ◽
Vol 28
(4)
◽
pp. 804-808
◽
E. Jonasch
◽
E. Hasanov
◽
P.G. Corn
◽
T. Moss
◽
K.R. Shaw
◽
...
2019 ◽
Vol 18
(11)
◽
pp. e3552
G. Procopio
◽
G. Apollonio
◽
F. Cognetti
◽
R. Miceli
◽
M. Milella
◽
...
V. Grunwald
◽
M.N. Fishman
◽
T.E. Hutson
◽
A. Bair
◽
Y. Chen
◽
...
2015 ◽
Vol 33
(15_suppl)
◽
pp. TPS4579-TPS4579
◽
Martin Henner Voss
◽
Andrea Coates
◽
Edward Graeme Garmey
◽
Naomi B. Haas
◽
Thomas Hutson
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 4607-4607
◽
S. W. Ebbinghaus
◽
M. Hussain
◽
N. M. Tannir
◽
M. S. Gordon
◽
A. A. Desai
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. TPS4601-TPS4601
◽
Nizar M. Tannir
◽
Robert J. Motzer
◽
Neeraj Agarwal
◽
Ping-Yu Liu
◽
Samuel H. Whiting
◽
...
Thomas Powles
◽
Michael B. Atkins
◽
Bernard Escudier
◽
Robert J. Motzer
◽
Brian I. Rini
◽
...
2017 ◽
Vol 28
◽
pp. v328
◽
T.K. Choueiri
◽
C. Porta
◽
C. Suarez Rodriguez
◽
R. Alter
◽
P. Czaykowski
◽
...
2016 ◽
Vol 14
(4)
◽
pp. 304-313.e6
◽
Kathleen M. Mahoney
◽
Susanna Jacobus
◽
Rupal S. Bhatt
◽
Jiaxi Song
◽
Ingrid Carvo
◽
...
2019 ◽
Vol 20
(10)
◽
pp. 1386-1394
◽
Moshe C Ornstein
◽
Sumanta K Pal
◽
Laura S Wood
◽
Jackie M Tomer
◽
Brian P Hobbs
◽
...
R. Srinivasan
◽
D. Su
◽
L. Stamatakis
◽
M.M. Siddiqui
◽
E. Singer
◽
...